Home
/
Records
/
483 Response
/
SCA Pharmaceuticals, LLC

483 RESPONSE

•SCA Pharmaceuticals, LLC•October 20, 2023

FDA 483_RESPONSE - SCA Pharmaceuticals, LLC - October 20, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Record Details

This 483 RESPONSE record concerns SCA Pharmaceuticals, LLC, with an inspection on October 20, 2023.

Company: SCA Pharmaceuticals, LLC
Inspection Date: October 20, 2023
People: Lisa M. Harlan (Program Division Director)
Scott Luce

Open in Dashboard

ID · 910fa2fc-9042-43cb-a938-e5d86530779c

Violation Codes1

FD&C Act 503B(a)(10)(A)

Full citation text and observation details available on the Dashboard.

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

[email protected]

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA 483_RESPONSE - SCA Pharmaceuticals, LLC - October 20, 2023 | Global Key Solutions